Background: Asthma is very prevalent in all grades of severity of anaphylaxis and asthma and Chronic obstructive pulmonary disease (COPD) have been associated with severity of anaphylaxis.
Introduction
Respiratory diseases and other factors [1] [2] [3] [4] 5] are major risk factors for increased severity of anaphylaxis [6, 7] . Asthma is associated with the severity of anaphylaxis [4, [8] [9] [10] [11] [12] [13] [14] [15] . Its sensitivity for predicting severity is high, while its specificity is low, owing to the marked presence of asthma in patients with food anaphylaxis in all grades of severity [7, 11, 15] . When addressing the option of exploring the relationship between severity of anaphylaxis and severity of asthma, few authors have investigated the relationship between uncontrolled asthma and severity of anaphylaxis [11, 15] . Chronic obstructive pulmonary disease (COPD) has been associated with severity of anaphylaxis in only three studies [1, 9, 12] .
The influence of respiratory diseases and the weaknesses of the various studies on severity of anaphylaxis have not been examined systematically. Consequently, our aims in this study are to evaluate the quality of evidence for the relationship between presence of respiratory diseases and severity of anaphylaxis and to determine to what extent it is affected by the presence of various confounders.
Methods
The study was designed according to the recommendations of the Meta-analysis of Observational Studies in Epidemiology [16] checklist and PRISMA Statement for systematic reviews [17] . The meta-analysis was registered in the PROSPERO database (No. CRD42018086042).
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Data collection and extraction
We designed an electronic data extraction form to collect the following: (1) study data (first author, year of publication, country, type of anaphylaxis); (2) [18] and Ring and Messmer [19] , admissions to hospital wards or critical care areas, hypotension, use of mechanical ventilation). One author obtained the information and the other checked its accuracy. Disagreement was resolved by consensus (EFA and MMM).
Given the observational nature of the studies included in the systematic review, our priority was to find adjusted statistics (odds ratios [OR]) ( Table 1 ).
In order not to include the same patients several times, we chose only the most severe outcome in each study. When the same group published several reports about the same exposure in different years (for instance anaphylaxis due to hymenoptera venom), duplication of participants was ruled out if the exposure occurred under different circumstances (e.g. hymenoptera anaphylaxis in the field or after the build-up or maintenance phase of venom immunotherapy).
grades. The risk of bias in individual studies was assessed by EFA and MAT.
Ethical Approval
Given that our study was a review of published literature, approval was not requested from our local ethics committee.
Summary Measures and Meta-analysis
Severity of anaphylaxis was modeled as a binary variable independently of the criterion used to establish severity in each study. ORs with a 95% confidence interval (CI) were calculated as a summary measure, since some studies make it possible to conclude that for the severity of anaphylaxis, the OR is a good marker of relative risk, because of the low prevalence of severe anaphylaxis. In a meta-analysis of food anaphylaxis [22] , the incidence rate of anaphylaxis requiring admission to hospital (as a proxy of severity) was 6.4% of the incidence rate of food anaphylaxis.
The heterogeneity of the studies was measured using the I 2 statistic (inconsistency) [23] .
Given the probable heterogeneity of the studies, we performed the meta-analysis using a random-effects model following the approach of DerSimonian and Laird. In the case of cells with zero in the contingency table, 0.5 was added to enable the analysis. For this meta-analysis, we performed an additional meta-analysis without these studies in order to assess the possible changes produced by our approach [24] . Likewise, in order to account for the heterogeneity of the studies, we used meta-regression models, by means of which we checked whether the design, type of anaphylaxis, outcome, and presence of adjustment played a relevant role in determining heterogeneity. Other variables not included in the regression models were age and population, owing to the fact that they were grouped very heterogeneously. Bias due to small sample size was assessed by analyzing the symmetry of the funnel plot and using Egger's test in the case of the meta-analysis based on ≥10 studies owing to the low power associated with a low number of studies [25] . Therefore, this approach was only used in the meta-analyses of all respiratory and all asthma studies and in the cross-sectional studies on both diseases. All statistical analyses were carried out using STATA™, version 15.1.
Results

Selection of studies
Our literature search revealed 5354 publications on respiratory disease (Figure 1 ), of which 1818 (33.96%) were related to asthma (1774) or COPD (92). After exclusion of duplicate studies, the number of publications decreased to 3437. A further 3296 articles were excluded during the screening phase. One article [26] was identified by checking the references of the excluded articles. Of the remaining 142 studies, 129 were excluded because they did not have available risk estimates. Therefore, 13 met our criteria for inclusion in the review [1] [2] [3] [4] 8, 9, [11] [12] [13] [14] [27] [28] [29] and had data for the quantitative analysis (Table 1 ). Almost all of the studies were cross-sectional observational studies, and only 1 was a case-control study [8] . The studies were published from 1993 to December 2017. All studies for cardiovascular and respiratory diseases were published in English.
Characteristics of the studies
The 13 studies on respiratory disease brought together 67,948 episodes ( Table 2 and 3) .
With respect to severity, the most frequent analysis was carried out in studies analyzing the main causes of anaphylaxis (6 from 13 for respiratory disease), whereas anaphylaxis due to drugs was the second cause of anaphylaxis studied (3 from respiratory disease).
The number of different outcomes in the severity studies was 10 for respiratory disease.
Presence of respiratory disease was assessed based on the criteria used in the clinical records (9), although up to 4 additional approaches were followed by other authors ( In the case of severity, the authors followed various strategies to control for confounders. Seven confounders were frequently identified, the most common being age, sex, cardiovascular diseases, and type of anaphylaxis (9, 7, 5, and 3 studies, respectively). Analysis of bias using the Newcastle-Ottawa scale [20] showed that except for 2 studies, the remaining studies yielded scores equal to 7. Table 2 shows individual studies with their contingency tables.
Effects of respiratory disease on severity of anaphylaxis
All respiratory diseases
In this meta-analysis, respiratory disease increased the severity of anaphylaxis (OR, 1.87; 95% CI, 1.30-2.70). The general analysis of the studies revealed heterogeneity (I 2 =87.3%, p<0.001). The study of Ha et al [26] had 0 events in some of the cells in the contingency table (Table 2) . We therefore performed an additional meta-analysis without this study, and the OR remained almost unchanged (OR, 1.89; 95% CI, 1.30-2.73). The separate analysis of adjusted studies also showed the presence of a significant OR (OR, 1.71; 95% CI, 1.15-2.54) and heterogeneity (I 2 =90.5%, p<0.001).
The OR was also significant in the 4 non-adjusted studies (OR, 2.77; 95% CI, 1.05-7.32). Examination of this meta-analysis did not reveal heterogeneity (I 2 =42.5%, p=0.16) ( Figure 2 , Table 3 ). The meta-regression analysis did not reveal any variants that explained the heterogeneity.
The funnel plot did not show presence of small studies with high effects, and findings were confirmed with the Egger test (p=0.11) ( Figure 3 ). Overall, asthma increased the severity of anaphylaxis (OR, 1.89; 95% CI, 1.26-2.83), albeit with heterogeneity (I 2 =91.1%; 95% CI, 91.1% p<0.001). The study of Ha et al [26] once again had 0 values in some of the cells in the contingency table, and the OR was very similar in the meta-analysis with and without the authors' data (OR, 1.90; 95% CI, 1.26-2.86) ( Figure 4 ). The meta-analysis of adjusted and non-adjusted studies showed that asthma was associated with greater severity of anaphylaxis ( Table 3 ). The meta-analysis of adjusted studies showed heterogeneity, whereas that of non-adjusted studies did not. Once again, none of the covariables used in the meta-regression model were able to account for this heterogeneity.
Presence of asthma
The funnel plot shows the absence of small studies with effects that favored severity of anaphylaxis, while the results of the Egger test for small effect bias were significant (p=0.036) ( Figure 3 ).
Presence of COPD
Only 3 studies [1, 9, 12] were available to study the relationship between COPD and severity of anaphylaxis (2 with adjusted studies and 1 with non-adjusted studies). For the meta-analysis of all studies (adjusted and non-adjusted), COPD increased the severity of anaphylaxis (OR, 2.47; 95% CI, 1.46-4.18). Heterogeneity was recorded in this meta-analysis (I 2 =70.6%, p=0.033). The meta-analysis of 2 adjusted studies showed similar ORs, although heterogeneity was high without reaching statistical significance (I 2 =70.5%, p=0.066) ( Table 3) .
Quality of evidence of the meta-analysis
As for the quality of evidence for the relationship between severity of anaphylaxis and respiratory disease, application of the GRADE system showed the quality of evidence to J Investig Allergol Clin Immunol 2021; Vol. 31 (2) © 2019 Esmon Publicidad doi: 10.18176/jiaci.0462 be moderate for studies assessing COPD, low for asthma (with no separation between adjusted and non-adjusted studies), and very low for all respiratory diseases using individual adjusted studies and all studies ( Table 4 ).
Discussion
Severity of anaphylaxis
Our meta-analysis showed that respiratory diseases increased the severity of anaphylaxis in studies that were adjusted or not adjusted for individual studies.
However, according to the recommendations of the GRADE guidelines [30] , the quality of evidence was only moderate for meta-analyses of all studies on COPD and low for adjusted meta-analyses including all studies on asthma. Consequently, our initial observations must be interpreted with some degree of caution because of the known and unknown confounders that are classically associated with observational studies.
Differences in prognosis in exposed and unexposed populations mean that observational studies carry a risk of bias [21, 31] , since they cannot control for confounders owing to the fact that the groups are not chosen randomly [31, 32] .
According to the GRADE framework, evidence from observational studies is low [30] .
However, the risk of bias is diminished if methodologically rigorous observational studies are performed (those that comprehensively and accurately measure prognostic factors associated with the outcome of interest), if the studies minimize loss to followup (the worst reported characteristic in the studies in our systematic reviews), if the 2 groups are similar (similar time, place, and population, as in our study), and if the analysis is an adjusted analysis that controls for differences in the distribution of J Investig Allergol Clin Immunol 2021; Vol. 31 (2) © 2019 Esmon Publicidad doi: 10.18176/jiaci.0462 prognostic factors between exposure and control groups (as in 12 of 13 studies in the present review). In addition, if the studies show a sufficiently large effect (RR >2 and strength >5), it seems reasonable to consider this effect real [20, 30] . These conclusions can translate to ORs if the baseline risk is 20% or lower [20, 30] . If the studies meet these conditions, evidence can be upgraded to moderate.
In the case of respiratory disease, the association with advanced cardiovascular disease [33] can confound the effect of respiratory disease on severity of anaphylaxis. However, this confounding effect is mainly for COPD and other respiratory diseases and is much less pronounced for asthma, a disease associated with younger age groups. In the case of COPD, the effect of cardiovascular disease was not controlled for in the study of Clark et al [8] , although it was controlled for in the studies by Mulla and Simmons and Worm et al [1, 12] . This finding, together with the strength of the OR [30] , means that the quality of evidence for the increase in the effect of COPD on severity of anaphylaxis is moderate according to the GRADE score (1 step below the maximum score). In the case of asthma, the quality of evidence was low (1 step below moderate) because the OR was less than 2, despite being less affected by possible confounding factors. Asthma has traditionally been considered a very sensitive risk factor for severe anaphylaxis and fatal anaphylaxis, although specificity was low for many patients with food anaphylaxis (severe and not severe) who had asthma as a comorbid condition [6] . In their fatal anaphylaxis series, Pumphrey et al [14] reported that many deaths involved patients with uncontrolled asthma. However, in our review, only the study by Summers et al [10] analyzed whether moderate or severe asthma increased the severity of anaphylaxis more than mild asthma and found non-significant differences between both.
Likewise, age can be a confounding factor for the severity of anaphylaxis and COPD.
However, we cannot carry out a meta-analysis of age and severity of anaphylaxis because assessment of age was very heterogeneous in the individual studies (2 values under or over a cut-off, age-group variables).
Limitations of the study
We added 0.5 in those cells containing zero values. For meta-analyses that excluded or did not exclude these studies, neither the statistical significance nor the fact that the OR was higher or lower than 1 changed after excluding these studies (data not shown).
In studies assessing small study bias or publication bias, the Egger test and the funnel plots revealed bias in very few meta-analyses, as in the case of the meta-analysis of asthma effects on severity of anaphylaxis. Harris et al [22] considered the Egger test to be conservative and frequently suggest that caution is needed when interpreting the results of meta-analyses. Using the qualitative funnel plot, most studies did not seem to show the large facilitating effects of small studies.
Our findings were also limited by the heterogeneity of the studies assessed: several studies were carried out in different clinical settings, anaphylaxis occurred during different diagnostic or therapeutic protocols, there was not common criteria on the diagnosis of anaphylaxis, the types of anaphylaxis and the criteria used to diagnose respiratory diseases were different, and the categories of respiratory diseases may have been too broad and ambiguous ( interpreted with caution owing to the heterogeneity of the studies included in our review.
Nevertheless, we did make an effort to obtain as much information as possible on the type respiratory diseases analyzed in the review. This is very evident in the analysis of respiratory disease, where characterization covers almost all of the studies (from 13 studies, asthma was the disease analyzed in 7 and COPD in 4) as shown in Tables 1 and   2 .
Another weakness of our meta-analysis is that some of the markers of severity chosen by the authors of the studies reviewed, such as admissions, may be more related to prognostic factors owing to an increased number of comorbidities that force clinicians to opt for more conservative management.
To our knowledge, no studies have evaluated the correlation between the different anaphylaxis severity scores; therefore, it seems that heterogeneity of outcomes does not explain the heterogeneity of the meta-analyses. The authors use the highest grade(s) of severity, which are similar in each organ and system evaluated. On the other hand, when authors do not use these scores, individual proxies of severity belong to extreme grades or the 2 highest grades of severity.
On the other hand, analyzing more than 2 grades of severity can be more informative, Finally, the presence of 4 studies (from 13) where anaphylaxis was diagnosed based on ICD-9-CM codes could be considered a weakness of our study. Walsh et al. [34] found a positive predictive value of 63.1% for ICD-9-CM codes in the diagnosis of anaphylaxis and wide variability between the 5 health organizations that provided patient records (from 48.1% to 78.9%). In other words, while ICD-9-CM has considerable external validity, it only has moderate internal validity.
Summary
The authors of the GRADE guidelines recommend not rating up for a large effect size if there are major problems associated with accuracy, publication bias, and the risk of bias (a confounding factor for cardiovascular disease and COPD in the present review) [20] .
Therefore, evidence obtained according to the GRADE guidelines will generally be low to moderate for the influence of respiratory diseases on severity of anaphylaxis if we apply the 4 grades for quality of evidence as a continuous scale.
In summary, for respiratory disease, the meta-analysis revealed the quality of evidence to be low to moderate, although not owing to the confounding effects, but rather to the widespread presence of asthma in severe and non-severe anaphylaxis. A series of studies should be conducted to determine whether the different degrees of severity of asthma are associated to different extents with the different grades of severity of anaphylaxis. Figure 1 . PRISMA flow diagrams summarizing the study selection process for respiratory diseases. 
Figures
